NO166127C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-substituerte difenylpiperidiner. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-substituerte difenylpiperidiner.

Info

Publication number
NO166127C
NO166127C NO863978A NO863978A NO166127C NO 166127 C NO166127 C NO 166127C NO 863978 A NO863978 A NO 863978A NO 863978 A NO863978 A NO 863978A NO 166127 C NO166127 C NO 166127C
Authority
NO
Norway
Prior art keywords
piperidines
preparation
therapeutically active
substituted diphenyl
analogy procedure
Prior art date
Application number
NO863978A
Other languages
English (en)
Other versions
NO166127B (no
NO863978D0 (no
NO863978L (no
Inventor
John Guilfoyle Mullin
Joseph Triscari
Richard Wightman Kierstead
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO863978D0 publication Critical patent/NO863978D0/no
Publication of NO863978L publication Critical patent/NO863978L/no
Publication of NO166127B publication Critical patent/NO166127B/no
Publication of NO166127C publication Critical patent/NO166127C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO863978A 1985-10-07 1986-10-06 Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-substituerte difenylpiperidiner. NO166127C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/785,113 US4632925A (en) 1985-10-07 1985-10-07 N-substituted diphenylpiperidines and antiobesity use thereof

Publications (4)

Publication Number Publication Date
NO863978D0 NO863978D0 (no) 1986-10-06
NO863978L NO863978L (no) 1987-04-08
NO166127B NO166127B (no) 1991-02-25
NO166127C true NO166127C (no) 1991-06-05

Family

ID=25134481

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863978A NO166127C (no) 1985-10-07 1986-10-06 Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-substituerte difenylpiperidiner.

Country Status (23)

Country Link
US (1) US4632925A (no)
EP (1) EP0221376B1 (no)
JP (1) JPH0633254B2 (no)
KR (1) KR870003984A (no)
AR (1) AR241422A1 (no)
AT (1) ATE53997T1 (no)
AU (1) AU593844B2 (no)
CA (1) CA1281326C (no)
DE (1) DE3672134D1 (no)
DK (1) DK168291B1 (no)
ES (1) ES2005074A6 (no)
FI (1) FI85020C (no)
GR (1) GR862513B (no)
HU (1) HU196200B (no)
IE (1) IE59434B1 (no)
IL (1) IL80232A0 (no)
MC (1) MC1769A1 (no)
NO (1) NO166127C (no)
NZ (1) NZ217798A (no)
PH (1) PH24167A (no)
PT (1) PT83495B (no)
SG (1) SG17593G (no)
ZA (1) ZA867375B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN163948B (no) * 1986-01-17 1988-12-10 Robins Co Inc A H
GB9000305D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Anticholinergic agents
DE69109871T2 (de) * 1990-10-10 1995-09-14 Schering Corp Pyridin- und pyridin-n-oxid-derivate von diarylmethyl- piperidinen oder piperazinen, deren zusammensetzungen und anwendung.
ES2089815T3 (es) * 1992-03-27 1996-10-01 Schering Corp Derivados de bis-aril-carbinol sin enlaces de puente, composiciones y metodos de uso.
US6184234B1 (en) * 1994-03-01 2001-02-06 Fmc Corporation Insecticidal N-(substituted arylmethyl)-4-[bis(substituted phenyl or pyridyl)methyl]piperidines
US6030987A (en) * 1996-05-17 2000-02-29 Fmc Corporation Insecticidal N-(substituted arylmethyl)-4-[bis(substituted phenyl or pyridyl)methyl]piperidines
US5639763A (en) * 1994-03-01 1997-06-17 Fmc Corporation Insecticidal N-(substituted arylmethyl)-4-[bis(substituted phenyl)methyl]piperidines
US6017931A (en) * 1994-03-01 2000-01-25 Fmc Corporation Insecticidal compositions containing n-(substituted phenylmethyl)-4-[bis(substituted phenyl)methyl]piperidines
ES2187652T3 (es) * 1995-05-19 2003-06-16 Fmc Corp N-(arimetil-sustutuidas-4-(bis(fenil o piridil sustituidas)metil) piperidinas insecticidas.
EP1026160A4 (en) 1997-09-16 2003-01-22 Takeda Chemical Industries Ltd CONNECTIONS WITH NITROGEN-CONDENSED RINGS, METHOD FOR THEIR PRODUCTION AND MEDICINES
US20100064413A1 (en) * 2008-03-14 2010-03-18 Simply Weights, LLC Exercise clothing and accessories
BRPI0911159A2 (pt) * 2008-04-29 2015-10-06 Hoffmann La Roche compostos derivados de ácido 4-dimetilaminobutírico, processo para a sua preparação, composições farmacêuticas que os compreendem, método para o tratamento terapêutico ou profilático de enfermidades que são moduladas por inibidres de cpt2 e uso destes compostos
AU2009242241B2 (en) 2008-04-29 2014-01-16 F. Hoffmann-La Roche Ag 4-trimethylammonio-butyrates as CPT2 inhibitors
EP3737680A1 (en) 2018-01-08 2020-11-18 F. Hoffmann-La Roche AG Octahydropyrido[1,2-alpha]pyrazines as magl inhibitors
IL299664A (en) 2020-09-03 2023-03-01 Hoffmann La Roche Heterocyclic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4076717A (en) * 1971-12-15 1978-02-28 G. D. Searle & Co. Derivatives of 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid
US3931197A (en) * 1974-02-08 1976-01-06 Richardson-Merrell Inc. Substituted piperidine derivatives
US4650874A (en) * 1984-11-26 1987-03-17 G. D. Searle & Co. N-(aralkoxybenzyl)-4(benzhydryl) piperidines

Also Published As

Publication number Publication date
EP0221376B1 (de) 1990-06-20
DE3672134D1 (de) 1990-07-26
AU6350186A (en) 1987-04-09
PT83495B (pt) 1989-05-31
US4632925A (en) 1986-12-30
ATE53997T1 (de) 1990-07-15
PT83495A (en) 1986-11-01
JPS6287585A (ja) 1987-04-22
FI85020C (fi) 1992-02-25
HU196200B (en) 1988-10-28
NO166127B (no) 1991-02-25
HUT41768A (en) 1987-05-28
NZ217798A (en) 1989-10-27
JPH0633254B2 (ja) 1994-05-02
IL80232A0 (en) 1987-01-30
PH24167A (en) 1990-03-22
AU593844B2 (en) 1990-02-22
IE59434B1 (en) 1994-02-23
FI864051A0 (fi) 1986-10-07
KR870003984A (ko) 1987-05-06
GR862513B (en) 1987-02-09
DK168291B1 (da) 1994-03-07
IE862636L (en) 1987-04-07
DK475286D0 (da) 1986-10-03
MC1769A1 (fr) 1987-07-17
FI85020B (fi) 1991-11-15
AR241422A1 (es) 1992-07-31
EP0221376A3 (en) 1987-09-02
NO863978D0 (no) 1986-10-06
EP0221376A2 (de) 1987-05-13
NO863978L (no) 1987-04-08
FI864051A (fi) 1987-04-08
DK475286A (da) 1987-04-08
ZA867375B (en) 1987-05-27
ES2005074A6 (es) 1989-03-01
SG17593G (en) 1993-05-21
CA1281326C (en) 1991-03-12

Similar Documents

Publication Publication Date Title
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO173544C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2- tiometyl-substituerte 1,4-dihydropyridiner
NO169543C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive peptidaseinhibitorer
NO864879D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser.
NO168422C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-substituerte benzamider
NO162858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater.
NO166127C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-substituerte difenylpiperidiner.
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO167569C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO167912C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aromatiske forbindelser
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO168107C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridiner
NO178069C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive platinakomplekser
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO168706C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-heterosyklisk substituerte benzamider.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO168105C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridinsubstituerte oxazoloner
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO167923C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive peptidsubstituerte heterocykliske forbindelser